Company Comparison
Roivant Sciences vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Roivant Sciences | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | New York City as well as major offices in the biotech hubs of Boston and Basel | Lagos, Nigeria |
| Founded | 2014 | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Roivant Sciences
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Roivant Sciences
Sector Overlap
Both Roivant Sciences and 54gene operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.